Capital I 2020 F2 - Net Worth and Insider Trading
Capital I 2020 F2 Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Capital I 2020 F2 owns 1 companies in total, including AlloVir Inc (ALVR) .
Click here to see the complete history of Capital I 2020 F2’s form 4 insider trades.
Insider Ownership Summary of Capital I 2020 F2
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALVR | AlloVir Inc | 2022-07-28 | director & 10 percent owner |
Capital I 2020 F2 Trading Performance
Capital I 2020 F2 Ownership Network
Ownership Network List of Capital I 2020 F2
Ownership Network Relation of Capital I 2020 F2
Capital I 2020 F2 Owned Company Details
What does AlloVir Inc do?
Who are the key executives at AlloVir Inc?
Capital I 2020 F2 is the director & 10 percent owner of AlloVir Inc. Other key executives at AlloVir Inc include director & 10 percent owner & See Remarks Vikas Sinha , General Counsel Edward Miller , and Chief Accounting Officer Brett R Hagen .
AlloVir Inc (ALVR) Insider Trades Summary
Over the past 18 months, Capital I 2020 F2 made no insider transaction in AlloVir Inc (ALVR). Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 193,383 shares made by Diana Brainard , a net sale of 65,497 shares made by Brett R Hagen , and a net sale of 82,092 shares made by Vikas Sinha .
In summary, during the past 3 months, insiders sold 50,935 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 50,935 shares. During the past 18 months, 364,999 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,565,871 shares.
AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.
AlloVir Inc Insider Transactions
Capital I 2020 F2 Mailing Address
Above is the net worth, insider trading, and ownership report for Capital I 2020 F2. You might contact Capital I 2020 F2 via mailing address: 8 West 38th Street, Suite 1001, New York Ny 10018.